Monoclonal antibody drugs such as lecanemab and donanemab, which target amyloid-beta proteins, help somewhat to slow the ...

A new case series from the U.K. National Prion Clinic bolstered earlier findings that suggested Alzheimer's disease could be ...

House Reps. Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.), co-sponsors of the Alzheimer’s Screening and Prevention (ASAP) ...

Dear Abby: I have been friends with my neighbor “Mary” for 30 years. She has developed Alzheimer’s disease and needs constant ...

Live at 9 ...

Most people think of Alzheimer’s disease as an illness of aging. But in fact, the brain changes that characterize it begin ...

A neurologist explains how insurance companies deny or delay Alzheimer's treatments, causing irreversible cognitive decline ...

Using AI to analyze changes in brain scans can predict Alzheimer’s with nearly 93 percent accuracy, scientists say.

Funded by a two-year, nearly $350,000 grant from the National Institutes of Health’s National Institute on Aging, the University of Cincinnati’s Shawn Xiong, PhD, is analyzing real-world patient data ...

Researchers have identified a new enzyme target that may influence multiple processes linked to Alzheimer’s disease, ...

Alzheimer's disease is most commonly associated with memory impairment, disorientation, and irreversible neurodegenerative ...

More than 7 million Americans live with Alzheimer's disease, with health and long-term care costs for AD and other forms of ...